Michael Scolaro

Michael Scolaro

Sep 16, 2017

Group 6 Copy 162
3
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Developing a new treatment for Ebola Virus Disease

Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

Backer Badge Funded